Vaishali Pharma Limited

NSEI:VAISHALI 株式レポート

時価総額：₹1.7b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

Vaishali Pharma バランスシートの健全性

財務の健全性 基準チェック /46

Vaishali Pharmaの総株主資本は₹428.4M 、総負債は₹126.1Mで、負債比率は29.4%となります。総資産と総負債はそれぞれ₹799.6Mと₹371.2Mです。 Vaishali Pharmaの EBIT は₹26.6Mで、利息カバレッジ比率1.5です。現金および短期投資は₹15.8Mです。

主要情報

29.4%

負債資本比率

₹126.10m

負債

インタレスト・カバレッジ・レシオ0.4x
現金₹15.78m
エクイティ₹428.39m
負債合計₹371.16m
総資産₹799.56m

財務の健全性に関する最新情報

Is Vaishali Pharma (NSE:VAISHALI) A Risky Investment?

Dec 11
Is Vaishali Pharma (NSE:VAISHALI) A Risky Investment?

Vaishali Pharma (NSE:VAISHALI) Seems To Use Debt Quite Sensibly

Dec 10
Vaishali Pharma (NSE:VAISHALI) Seems To Use Debt Quite Sensibly

These 4 Measures Indicate That Vaishali Pharma (NSE:VAISHALI) Is Using Debt Reasonably Well

Feb 10
These 4 Measures Indicate That Vaishali Pharma (NSE:VAISHALI) Is Using Debt Reasonably Well

Does Vaishali Pharma (NSE:VAISHALI) Have A Healthy Balance Sheet?

Jan 19
Does Vaishali Pharma (NSE:VAISHALI) Have A Healthy Balance Sheet?

Recent updates

Here's Why Vaishali Pharma (NSE:VAISHALI) Has Caught The Eye Of Investors

Jan 17
Here's Why Vaishali Pharma (NSE:VAISHALI) Has Caught The Eye Of Investors

Vaishali Pharma Limited's (NSE:VAISHALI) Shares Leap 30% Yet They're Still Not Telling The Full Story

Dec 18
Vaishali Pharma Limited's (NSE:VAISHALI) Shares Leap 30% Yet They're Still Not Telling The Full Story

Is Vaishali Pharma (NSE:VAISHALI) A Risky Investment?

Dec 11
Is Vaishali Pharma (NSE:VAISHALI) A Risky Investment?

We Ran A Stock Scan For Earnings Growth And Vaishali Pharma (NSE:VAISHALI) Passed With Ease

Oct 04
We Ran A Stock Scan For Earnings Growth And Vaishali Pharma (NSE:VAISHALI) Passed With Ease

With EPS Growth And More, Vaishali Pharma (NSE:VAISHALI) Makes An Interesting Case

Feb 04
With EPS Growth And More, Vaishali Pharma (NSE:VAISHALI) Makes An Interesting Case

Vaishali Pharma (NSE:VAISHALI) Seems To Use Debt Quite Sensibly

Dec 10
Vaishali Pharma (NSE:VAISHALI) Seems To Use Debt Quite Sensibly

We Ran A Stock Scan For Earnings Growth And Vaishali Pharma (NSE:VAISHALI) Passed With Ease

Aug 20
We Ran A Stock Scan For Earnings Growth And Vaishali Pharma (NSE:VAISHALI) Passed With Ease

Should You Be Adding Vaishali Pharma (NSE:VAISHALI) To Your Watchlist Today?

May 19
Should You Be Adding Vaishali Pharma (NSE:VAISHALI) To Your Watchlist Today?

These 4 Measures Indicate That Vaishali Pharma (NSE:VAISHALI) Is Using Debt Reasonably Well

Feb 10
These 4 Measures Indicate That Vaishali Pharma (NSE:VAISHALI) Is Using Debt Reasonably Well

A Look At The Intrinsic Value Of Vaishali Pharma Limited (NSE:VAISHALI)

Aug 17
A Look At The Intrinsic Value Of Vaishali Pharma Limited (NSE:VAISHALI)

A Look At The Fair Value Of Vaishali Pharma Limited (NSE:VAISHALI)

May 17
A Look At The Fair Value Of Vaishali Pharma Limited (NSE:VAISHALI)

Are Vaishali Pharma Limited's (NSE:VAISHALI) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?

Mar 17
Are Vaishali Pharma Limited's (NSE:VAISHALI) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?

Calculating The Fair Value Of Vaishali Pharma Limited (NSE:VAISHALI)

Feb 15
Calculating The Fair Value Of Vaishali Pharma Limited (NSE:VAISHALI)

Does Vaishali Pharma (NSE:VAISHALI) Have A Healthy Balance Sheet?

Jan 19
Does Vaishali Pharma (NSE:VAISHALI) Have A Healthy Balance Sheet?

Are Vaishali Pharma Limited's (NSE:VAISHALI) Mixed Financials Driving The Negative Sentiment?

Nov 23
Are Vaishali Pharma Limited's (NSE:VAISHALI) Mixed Financials Driving The Negative Sentiment?

財務状況分析

短期負債: VAISHALIの 短期資産 ( ₹745.2M ) が 短期負債 ( ₹330.8M ) を超えています。

長期負債: VAISHALIの短期資産 ( ₹745.2M ) が 長期負債 ( ₹40.3M ) を上回っています。

デット・ツー・エクイティの歴史と分析

負債レベル: VAISHALIの 純負債対資本比率 ( 25.8% ) は 満足できる 水準であると考えられます。

負債の削減: VAISHALIの負債対資本比率は、過去 5 年間で79.8%から29.4%に減少しました。

債務返済能力: VAISHALIの負債は 営業キャッシュフロー によって 十分にカバーされていません ( 6.4% )。

インタレストカバレッジ: VAISHALIの負債に対する 利息支払い は EBIT ( 1.5 x coverage) によって 十分にカバーされていません。

貸借対照表

健全な企業の発掘

7D

1Y

7D

1Y

7D

1Y